Cadrenal Therapeutics, Inc. Quarterly Return On Equity in % from Q4 2022 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Cadrenal Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2022 to Q3 2024.
  • Cadrenal Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was -143 %, a 69.5% increase year-over-year.
  • Cadrenal Therapeutics, Inc. annual Return On Equity for 2023 was -141 %, a 140% decline from 2022.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -143 +326 +69.5% Jul 1, 2024 Sep 30, 2024
Q2 2024 -93.7 +9.48K +99% Apr 1, 2024 Jun 30, 2024
Q1 2024 -75.1 -1.48K -105% Jan 1, 2024 Mar 31, 2024
Q4 2023 -141 -496 -140% Oct 1, 2023 Dec 31, 2023
Q3 2023 -468 Jul 1, 2023 Sep 30, 2023
Q2 2023 -9.57K Apr 1, 2023 Jun 30, 2023
Q1 2023 1.4K Jan 1, 2023 Mar 31, 2023
Q4 2022 355 Oct 1, 2022 Dec 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.